Why It’s Still a Great Time to Buy a da Vinci Si Surgical Robot

In a surgical tech landscape dominated by constant upgrades and high price tags, one system continues to quietly transform access to care around the world: the da Vinci Si.

Yes, the Si is a legacy platform. But in many hospitals, it’s also a lifeline.

At R2 Surgical, we believe the da Vinci Si still has a critical role to play in global healthcare—and we’re not just saying that because we sell them. We’re saying that because we support them too. In fact, we’re the only company in the world that does both.

The Only Global Source for Sales and Support of Pre-Owned da Vinci Systems

We pioneered our business with da Vinci Si systems. That means: We understand them inside and out. We’ve supported dozens of hospital launches using the Si. We’ve proven that, with proper care, these systems can go the distance.

R2 Surgical is the only global company that both sells and supports pre-owned da Vinci systems.

That includes:

• Certified pre-owned Si robots

• On-call technical support—yes, real humans

• Biomedical engineer training

• Clinical and sterile processing training

• Ongoing supply of instruments, accessories, and consumables

It’s one thing to drop off a robot. It’s another to build a working program. We do both.

That’s why our partners stick with us. And it’s why we believe the da Vinci Si is still one of the best investments in robotic surgery—especially for hospitals looking to stretch their capital without compromising on care.

Why the da Vinci Si Still Makes Sense in 2025

New da Vinci systems are expensive. For hospitals with limited capital, launching or expanding a robotic surgery program might feel out of reach. But the Si changes that.

Here’s why:

• Proven track record: The Si is still used every day in ORs around the world.

• Lower upfront costs: Especially valuable for emerging markets or resource-conscious health systems.

• Reliable and maintainable: With the right support (that’s us), these systems are built to last.

Real‑World Success: Venezuela, Ukraine & Turkey

These aren’t hypotheticals—they’re real, thriving da Vinci Si programs launched with support from R2 Surgical:

• Instituto Médico La Floresta (Venezuela, 2022)

  • Acquired a pre‑owned da Vinci Si with a 3‑year support plan covering 50 procedures.

  • Surgeons report improved precision, smaller incisions, and faster recoveries for patients.

  • Local teams received clinical, sterile processing, and technical training—ensuring long-term sustainability.

  • Responsive on-call support and proactive service visits have kept the system running at high performance.

• Lviv Hospital (Ukraine, 2023)

  • Built on early robotic success by adding a da Vinci Si system in 2023.

  • Performed over 145 robotic procedures across adult and pediatric cases, including colorectal, thoracic, gynecologic, and urologic surgeries.

  • Ongoing collaboration with R2 Surgical has helped the team scale their program confidently and consistently.

  • The hospital is now a training hub for robotic surgeons across Ukraine.

• Atasam Hospital (Turkey, 2022)

  • Installed a da Vinci Si with a 2‑year support plan tailored to meet both surgical and educational goals.

  • The program focuses on training surgeons and expanding access to robotic surgery in North‑Eastern Turkey.

Want to Learn More?

Contact us today to learn:

• What inventory we currently have available

• How we can help you stand up or sustain a program

• Whether an Si system is the right fit for your facility

The future of robotic surgery doesn’t have to be brand new. It just has to work—and keep working.

And with R2 Surgical, it will.